Neoprospecta
Florian├│polis
About Neoprospecta
Neoprospecta, a contract research company, uses high-throughput genomic sequencing and large scale bioinformatics to find new genes, enzymes, and other proteins from the biodiversity. It specializes in bioprospecting of new enzymes, peptides, and other proteins. Neoprospecta offers custom metagenomic bioprospection, contract research, enzyme development, and conservation biology services. Luiz Fernando Valter de Oliveira, Luiz Felipe Valter de Oliveira, Ronaldo Mota, and Marcos Carvalho founded it on January 21, 2011, with its headquarters in Florianópolis in Brazil.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Feb 2018)
- Website: neoprospecta.com
- Phone: +5548991067516
Industries & Categories
Analytics, Bioinformatics, Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/neoprospecta-3053475 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.